cAMP Gs dynamic kit
Optimal performance when applied to Gs activation or inhibition
The GTP Gi binding assay detects upstream Gi protein activity at the receptor, upon GPCR stimulation in membrane extracts. This HTRF-based non-isotopic assay is simple, fast, and has a no-wash format.
The assay uses GTP gamma S and is intended for GPCR model studies, and compound pharmacological identification and characterization.
The GTP Gi binding assay uses a cryptate-labelled GTP analog (donor) and a d2-labelled anti-Gi antibody (acceptor). The GTP analog specifically binds into the GTP-binding pocket of active G proteins, while the d2-labelled antibody is specific to the Gαi subunit of G proteins. GPCR activation in presence of the two detection reagents brings the donor and acceptor into proximity, which triggers a FRET signal with an intensity proportional to the concentration of active Gi protein in the sample. GTP gamma S, a non-hydrolysable GTP analog, is used to displace the donor from the GTP-binding pocket and extinguish FRET to determine the assay non-specific signal an ensure its accuracy.
The GTP Gi binding assay is performed in a miniaturized format using 20 µl final volume, and features a streamlined 4-step reagent addition protocol where stimulation/compounds, agonist, detection reagents, and membranes are added successively. Plates are read after 3H or ON incubation at RT, depending on the biological model. No washing steps are required.
This protocol uses optimized conditions previously determined for the biological model of interest (optimal membrane quantity/well, and supplemented Stimulation buffer #3 containing optimal concentrations of MgCL2 and GDP). The optimization procedure and recommendations are presented in the associated guides.
The assay was performed using the previously optimized conditions for this membrane model: stimulation buffer #3 was supplemented with 0.5 µM of GDP, 50 mM of MgCl2. The assay was performed using 5 µg of membranes / well. The SNC-162 dose-response curve fit shows an EC50 of 6.5 nM, which is in accordance with published values.
A case study in CHO-DOR membrane model with and without optimization of the MgCl2 and GDP concentrations in stimulation buffer. 5 µg of membrane were incubated in presence or absence of the SNC-162 agonist (1 µM). The plate was read after ON incubation at RT.Without optimization, the assay was strongly biased and showed no difference in signal between the GPCR basal activity and agonist-induced activity. The optimization step resulted in a significant decrease in the basal activity signal, thus highlighting the agonist-induced signal and resulting in a S/B of 2.8. The optimization recommendations and procedure are described in detail in the optimization section of the guides associated with the kit.
Optimal membrane quantity/well may change from one membrane model to another. An additional optimization step featuring three conditions (2.5, 5, and 10 µg/well) enables optimal membrane quantity determination. Two case studies are presented here:
The graphs show the signal obtained in absence (basal) or presence of agonist (stimulated). S/B is presented for each condition. As demonstrated here, membrane quantity/well is a key parameter for pharmacological S/B optimization. For these two models, 5 µg of membrane/well is suitable. This optimization step can be a deciding factor in enhancing assay S/B, or in selecting assay conditions using a lower quantity of membrane (2.5 µg/well for DOR).
In their inactive state, heterotrimeric G proteins bind GDP in a binding pocket of their Ga sub-unit. Upon stimulation of the GPCR by an agonist, the receptor-coupled G protein undergoes a conformational change that allows the Ga sub-unit to release its bound GDP and replace it with GTP. This nucleotide exchange fully activates the Ga sub-unit, which dissociates from the Gb/Gg dimer and performs inhibitory or stimulating functions on adenylate cyclase (AC) and phospholipase C (PLC), depending on its sub-type (Gai, Gas, Gaq, etc).
The following signal transduction steps are GPCR-specific and mobilize different phospho-proteins and pathways. Over time, the Ga-bound GTP undergoes hydrolysis, which returns the Ga protein to an inactive state.
See how peer researchers monitor GPCR signaling with HTRF - Notes d'application
Discover how to get the most out of your Gαi agonist and antagonist research with our HTRF GTP binding assays. - Guides
Characterization of candidate molecules through GTP binding assays - Notes d'application
Read this note featuring two case studies that demonstrate the relevance of combining upstream (GTP) and downstream (cAMP) readouts for characterizing pharmacological compounds - Notes d'application
62GTPPET-62GTPPEG-62GTPPEC - Protocoles
Evaluate a panel of GPCR membranes tested with the GTP Gi Binding Assay - Notes d'application
This video will show you how to use HTRF technology to quantify GTP recruitment by activated Gi protein - Vidéos
Choosing the right microplate reader ensures you’ll get an optimal readout. Discover our high performance reader, or verify if your lab equipment is going to be compatible with this detection technology.Let's find your reader
Advanced phospho-ERK (Thr202/Tyr204) cellular kit
Simple, all-in-one kit for robust detection of Phospho-ERK.